- Home
- SLAI vs YI Comparison
SLAI vs YI Comparison
Compare SLAI & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLAI
- YI
- Stock Information
- Founded
- SLAI 2001
- YI 2010
- Country
- SLAI United States
- YI China
- Employees
- SLAI N/A
- YI N/A
- Industry
- SLAI EDP Services
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- SLAI Technology
- YI Consumer Staples
- Exchange
- SLAI Nasdaq
- YI Nasdaq
- Market Cap
- SLAI 39.4M
- YI 38.1M
- IPO Year
- SLAI N/A
- YI N/A
- Fundamental
- Price
- SLAI $1.51
- YI $3.90
- Analyst Decision
- SLAI
- YI
- Analyst Count
- SLAI 0
- YI 0
- Target Price
- SLAI N/A
- YI N/A
- AVG Volume (30 Days)
- SLAI 182.3K
- YI 8.1K
- Earning Date
- SLAI 11-19-2025
- YI 12-01-2025
- Dividend Yield
- SLAI N/A
- YI N/A
- EPS Growth
- SLAI N/A
- YI N/A
- EPS
- SLAI N/A
- YI N/A
- Revenue
- SLAI $24,576,000.00
- YI $1,979,883,442.00
- Revenue This Year
- SLAI $14.32
- YI N/A
- Revenue Next Year
- SLAI N/A
- YI N/A
- P/E Ratio
- SLAI N/A
- YI N/A
- Revenue Growth
- SLAI N/A
- YI N/A
- 52 Week Low
- SLAI $1.22
- YI $3.69
- 52 Week High
- SLAI $8.07
- YI $11.35
- Technical
- Relative Strength Index (RSI)
- SLAI N/A
- YI 31.15
- Support Level
- SLAI N/A
- YI $3.87
- Resistance Level
- SLAI N/A
- YI $4.18
- Average True Range (ATR)
- SLAI 0.00
- YI 0.17
- MACD
- SLAI 0.00
- YI 0.01
- Stochastic Oscillator
- SLAI 0.00
- YI 43.21
About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
SOLAI Ltd is a cryptocurrency mining company. The company aims to build a comprehensive blockchain-based ecosystem that includes AI, stablecoins, payment infrastructure, and Solana treasury and staking operations.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.